GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)
INR 60.27
(-2.0%)
INR 60.27
(-2.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -60.73 Thousand INR | 85.3% |
| 2022 | -413.09 Thousand INR | -1441.91% |
| 2021 | -26.79 Thousand INR | -100.17% |
| 2020 | 15.35 Million INR | 6.56% |
| 2019 | 14.41 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 60.73 Thousand INR | 200.0% |
| 2023 Q3 | 408.61 Thousand INR | 268.88% |
| 2023 FY | -60.73 Thousand INR | 85.3% |
| 2023 Q2 | -241.95 Thousand INR | -158.57% |
| 2023 Q1 | 413.09 Thousand INR | 200.0% |
| 2023 Q4 | -60.73 Thousand INR | -114.86% |
| 2022 Q2 | -112.83 Thousand INR | 0.0% |
| 2022 Q4 | -413.09 Thousand INR | -466.09% |
| 2022 Q3 | 112.83 Thousand INR | 200.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 100.004% |
| Biocon Limited | 140.18 Billion INR | 100.0% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 99.993% |
| Concord Biotech Limited | -372.86 Million INR | 99.984% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 100.0% |
| FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 100.005% |
| Lyka Labs Limited | 527.01 Million INR | 100.012% |
| Panacea Biotec Limited | -1.18 Billion INR | 99.995% |
| SAMSRITA LABS LIMITED | 21.98 Million INR | 100.276% |
| Servoteach Industries Limited | 5016.00 INR | 1310.805% |
| SMS Lifesciences India Limited | 992.31 Million INR | 100.006% |
| Supriya Lifescience Limited | -694.68 Million INR | 99.991% |
| Syngene International Limited | -83 Million INR | 99.927% |
| TAKE Solutions Limited | 361.37 Million INR | 100.017% |
| Titan Biotech Limited | 54.62 Million INR | 100.111% |
| Transgene Biotek Limited | 139.93 Million INR | 100.043% |
| Vanta Bioscience Limited | 607.93 Million INR | 100.01% |